Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (8398)	5/19/2003 4:52:25 AM
From: Icebrg	Read Replies (2) \| Respond to of 52153

DNA - Avastin [One more on Genentech - then I will be quiet]. It is interesting to note that "market participants" seem to have been as surprised as I was about the early announcement. The results were supposed to be released sometimes during the summer. And we are not so far yet - at least not here in Sweden. Last Friday the share lost 5,4 % of its value. The volume was 2,5 times the normal at 6,561,000 shares. I believe there was an option expiry last Friday, but still. It is good that sellers learn that good news may also strike at any moment. Erik